Home U.S. Global Health Policy Program

View the Latest: U.S. Global Health Policy

Filter

List Grid

161 - 170 of 400 Results

  • As PEPFAR Nears its Two-Decade Mark, New Analysis Finds That Mortality Declined Substantially in PEPFAR Countries Over the Course of the Program

    News Release

    A new KFF analysis finds the President's Emergency Plan for AIDS Relief (PEPFAR) program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003. The new analysis takes a closer look at PEPFAR’s health impact by assessing the all-cause mortality rate in 90 PEPFAR recipient countries compared to similar low-and middle-income countries. The all-cause mortality rate was 20% lower than expected had PEPFAR been absent. PEPFAR countries with higher…

  • Assessing PEPFAR’s Impact: Analysis of Mortality in PEPFAR Countries

    Issue Brief

    As the PEPFAR program approaches its two-decade mark, this new analysis finds the program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003, suggesting that future investments will continue to yield significant health impacts.

  • Key Issues and Questions for PEPFAR’s Future

    Issue Brief

    This brief explores key issues and poses questions regarding PEPFAR’s future, providing a roadmap for the major decisions ahead for the program. It identifies eight key, interrelated issues facing the administration, Congress, and other PEPFAR stakeholders.

  • The Red/Blue Divide in COVID-19 Vaccination Rates

    Policy Watch

    This post examines a growing COVID-19 vaccine gap in Red and Blue America, with the share of the population that have been fully vaccinated in counties that voted for President Biden in 2020 increasing more rapidly than the share in counties that voted for President Trump.

  • Disparities in Global Vaccination Progress Are Large and Growing, With Low-Income Countries and Those in Africa Lagging Behind

    News Release

    A new KFF analysis finds that only 1% of those in low-income countries have received at least one vaccine dose compared to 51% in high-income countries, highlighting the substantial vaccine inequities around the world. The analysis examines these inequities by country income level and by region, finding large differences for each. By region, Africa has the lowest coverage (2%) while Europe has the highest (40%), followed by the Americas (39%) and the Western Pacific (37%).…

  • KFF/UNAIDS Analysis Finds That While Donor Government Spending on HIV Increased in 2020, Future Funding is Uncertain with COVID-19 Challenges

    News Release

    A new report from KFF (Kaiser Family Foundation) and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds that donor government disbursements to combat HIV in low- and middle-income countries increased by US$377 million in 2020, reaching US$8.2 billion in 2020 compared to US$7.8 billion in 2019. Donor government funding supports HIV care and treatment, prevention, and other services in low- and middle-income countries. The rise in funding is almost entirely the result of an…

  • Donor Government Funding for HIV in Low- and Middle-Income Countries in 2020

    Report

    This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2020, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).

  • House Appropriations Committee Releases FY 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations Bill

    Fact Sheet

    The House Appropriations Committee released the FY 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill on July 11, 2021 and accompanying report on July 14, 2021. The LHHS appropriations bill includes funding for U.S. global health programs provided to the Centers for Disease Control and Prevention (CDC) and funding for global health research activities provided to the National Institutes of Health (NIH).[i] Key highlights of known amounts are as follows (see table…

  • Funding for Key HIV Commodities in PEPFAR Countries

    Issue Brief

    In many low- and middle-income countries, PEPFAR and the Global Fund are significant funders of commodities to diagnose, treat, and prevent HIV, along with country governments. But, information on their relative contributions, which is important for assessing the HIV response, is not readily available. We analyzed data from PEPFAR documents on funding for key HIV commodities in 34 PEPFAR countries to better understand the funding landscape.